| 000 | 01672 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516083215.0 | ||
| 264 | 0 | _c20120730 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1745-7254 | ||
| 024 | 7 |
_a10.1038/aps.2011.177 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMa, Bo | |
| 245 | 0 | 0 |
_aStrontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway. _h[electronic resource] |
| 260 |
_bActa pharmacologica Sinica _cApr 2012 |
||
| 300 |
_a479-89 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFructosediphosphates _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xpharmacology |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xanalysis |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xblood |
| 650 | 0 | 4 |
_aOsteoprotegerin _xblood |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 |
_aRANK Ligand _xblood |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptor Activator of Nuclear Factor-kappa B _xblood |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aZhang, Qi | |
| 700 | 1 | _aWu, Di | |
| 700 | 1 | _aWang, Yong-lu | |
| 700 | 1 | _aHu, Ying-ying | |
| 700 | 1 | _aCheng, Yan-ping | |
| 700 | 1 | _aYang, Zhen-dong | |
| 700 | 1 | _aZheng, Ya-ya | |
| 700 | 1 | _aYing, Han-Jie | |
| 773 | 0 |
_tActa pharmacologica Sinica _gvol. 33 _gno. 4 _gp. 479-89 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/aps.2011.177 _zAvailable from publisher's website |
| 999 |
_c21631166 _d21631166 |
||